Consequently, we only had statistical power to detect signals with large effect sizes, such as APOE and GBA. We anticipate that GWAS with larger samples will detect more common genetic risk loci associated with DLB with effect sizes comparable to the vast majority of AD and PD GWAS loci. The gene discussed is APOE; the disease is Parkinson disease.